Total amount raised
$40.4 Million
Latest funding date
2/1/2024
Location
Zeno Health has successfully raised funds over four rounds, with the latest being a Series C led by STIC Investment. The company is backed by seven investors, including notable names like Lightbox and STIC Investment.
Keep reading to explore the intricacies of Zeno Health's fundraising journey and the investors backing this innovative platform.
What Is Zeno Health?
Zeno Health is a pharmacy company focused on providing generic medicines to make healthcare accessible and affordable. Based in Mumbai, Maharashtra, India, the company operates within the healthcare, medical, and pharmaceutical industries.
With an employee count ranging from 501 to 1000, Zeno Health has shown significant growth. The company has raised funds over multiple rounds and has acquired another company named TABLT.
How Much Funding Has Zeno Health Raised?
- Series A (2018-12-18)
- Amount Raised: USD 42,000
- Date: December 2018
- Lead Investors: Tomorrow Capital, Whiteboard Capital
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale operations and expand market reach.
- Series A (2019-09-19)
- Amount Raised: USD 14,000,000
- Date: September 2019
- Lead Investors: Lightbox
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand Zeno Health's footprint and improve its technological infrastructure.
- Debt Financing (2020-01-07)
- Amount Raised: USD 1,400,000
- Date: January 2020
- Lead Investors: Alteria Capital
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support operational expenses and growth initiatives.
- Series C (2024-02-27)
- Amount Raised: USD 25,000,000
- Date: February 2024
- Lead Investors: STIC Investment
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand Zeno Health's consumer base and enhance its technological infrastructure.
Total Amount Raised: USD 40,442,000. Current Valuation: Not publicly disclosed.
Key Investors
- STIC Investment
- Details: STIC Investment is a South Korean private equity and venture capital firm. They led the Series C funding round for Zeno Health.
- Investment Focus Areas: Healthcare, technology, consumer goods, industrials
- Notable Investments: Yanolja, Dunzo, Ninjacart
- Lightbox
- Details: Lightbox is a venture capital firm based in Mumbai, India. They have been a recurring investor in Zeno Health, participating in both Series A and Series C rounds.
- Investment Focus Areas: Technology, consumer internet, healthcare
- Notable Investments: Rebel Foods, Furlenco, Dunzo
- Alteria Capital
- Details: Alteria Capital is an Indian venture debt fund. They participated in the debt financing round for Zeno Health.
- Investment Focus Areas: Early and growth-stage companies, technology, healthcare
- Notable Investments: Dunzo, Lendingkart, ZestMoney
- Tomorrow Capital
- Details: Tomorrow Capital is an Indian investment firm focused on early-stage investments. They participated in the Series A funding round for Zeno Health.
- Investment Focus Areas: Consumer, technology, healthcare
- Notable Investments: Nykaa, Licious, Coverfox
- Whiteboard Capital
- Details: Whiteboard Capital is an early-stage venture capital firm based in India. They also participated in the Series A funding round for Zeno Health.
- Investment Focus Areas: Technology, consumer, healthcare
- Notable Investments: Dunzo, Furlenco, Rebel Foods
What's Next for Zeno Health?
With the recent $25 million Series C funding, Zeno Health is poised to expand its generic drug platform and pharmacy services, aiming to serve a larger consumer base and enhance its technological infrastructure. The substantial growth potential in the generic drug market, coupled with increasing demand for affordable healthcare, presents significant opportunities for the company.
Future fundraising rounds could be on the horizon as Zeno Health continues to scale its operations and improve its technological capabilities. The company may also attract strategic partnerships or investments from larger pharmaceutical companies, further bolstering its market position.
However, Zeno Health will need to navigate regulatory hurdles, manage competition from other generic drug providers, and ensure consistent drug quality. Despite these challenges, the company's commitment to making healthcare more accessible and affordable positions it well for continued success.
Use Clay to Get Funding Data
Sales professionals, leverage Clay’s platform to access comprehensive fundraising data on companies like Zeno Health and gather other critical business insights. Sign up for free to start unlocking valuable information today.
